Track topics on Twitter Track topics that are important to you
Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CEO
The post Roche’s Genentech agrees to buy Jecure Therapeutics appeared first on Pharmaceutical Business review.
Original Article: Roche’s Genentech agrees to buy Jecure TherapeuticsNEXT ARTICLE
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...